我国艾滋病流行演变及防控策略进展

汤后林

doi:10.19837/j.cnki.ahyf.2025.06.001

PDF(1084 KB)

安徽预防医学杂志 ›› 2025, Vol. 31 ›› Issue (6) : 437-441. DOI: 10.19837/j.cnki.ahyf.2025.06.001

特约专稿

我国艾滋病流行演变及防控策略进展

汤后林

作者信息 +

The evolution of AIDS epidemic in China and progress in prevention and control strategies

TANG Houlin

Author information +

文章历史 +

摘要

我国自1985年报告首例艾滋病病例以来，艾滋病疫情经历了从传入期、扩散期到以性传播为主的广泛流行期的复杂演变历程。该文系统回顾了我国艾滋病的流行演变、阶段性特征、防控策略的主要成效以及当前面临的挑战，通过深入分析国家政策演进、监测与检测体系完善、治疗与关怀服务拓展、公众宣传教育深化，以及多病协同防控等方面的进展，总结了我国在艾滋病防控实践中积累的重要经验。面对重点人群防控难度大、检测发现晚、防控能力不均衡等问题，探讨了未来防控工作的路径，强调应持续推进精准防控、强化体系整合与推动社会共治，为终结艾滋病流行目标提供参考。

Abstract

Since the first case of acquired immunodeficiency syndrome (AIDS) was reported in China in 1985, the epidemic of AIDS has undergone a complex evolution from an imported period, a diffusion period, to a generalized epidemic phase predominantly driven by sexual transmission. This article systematically reviews epidemic evolution, stage-specific characteristics, major achievements of prevention and control strategies, and current challenges of the AIDS in China. Through in-depth analysis of the national policies evolution, improvements of surveillance and detection system, expansion of treatment and care services, deepening of public health education, and coordinated prevention and control of multiple diseases, the important experience of AIDS prevention and control in China is summarized. In light of challenges such as difficulties in prevention and control of key populations, delayed detection, uneven prevention and control capabilities, and so on, the direction for future prevention and control work is discussed. It emphasizes the need to advance targeted interventions, strengthen system integration, and promote co-governance involving all sectors of society, thereby offering insights for achieving the goal of ending the AIDS epidemic.

导出引用

汤后林. 我国艾滋病流行演变及防控策略进展[J]. 安徽预防医学杂志. 2025, 31(6): 437-441 https://doi.org/10.19837/j.cnki.ahyf.2025.06.001

TANG Houlin. The evolution of AIDS epidemic in China and progress in prevention and control strategies[J]. Anhui Journal of Preventive Medicine. 2025, 31(6): 437-441 https://doi.org/10.19837/j.cnki.ahyf.2025.06.001

中图分类号： R197.1，R512.91

参考文献

列表( 原文顺序 | 文献年度倒序 | 文中引用次数倒序 ) 可视化分析

[1]	中国疾病预防控制中心性病艾滋病预防控制中心. 2024年12月全国艾滋病性病疫情[J]. 中国艾滋病性病, 2025, 31(3):225. 本文引用 [3]

[2]	Wu ZY, Chen JF, Scott SR, et al. History of the HIV epidemic in China[J]. Curr HIV/AIDS Rep, 2019, 16(6):458-466. https://doi.org/10.1007/s11904-019-00471-4 本文引用 [3]

[3]	曾毅, 王必瑺, 郑锡文, 等. 艾滋病的血清流行病学调查研究[J]. 中华流行病学杂志, 1988, 9(3):138-140. 本文引用 [1]

[4]	Cai C, Tang HL, Li DM, et al. Evolution of HIV epidemic and emerging challenges - China,1989-2023[J]. China CDC Wkly, 2024, 6(48):1251-1256. 本文引用 [5]

[5]	Wu ZY, Sullivan SG, Wang Y, et al. Evolution of China’s response to HIV/AIDS[J]. Lancet, 2007, 369(9562):679-690. https://doi.org/10.1016/S0140-6736(07)60315-8 https://linkinghub.elsevier.com/retrieve/pii/S0140673607603158 本文引用 [2]

[6]

, Han

, Jiang

, et al. Prevention and control of HIV/AIDS in China:lessons from the past three decades[J]. Chin Med J, 2021, 134(23):2799-2809.

https://doi.org/10.1097/CM9.0000000000001842

https://journals.lww.com/10.1097/CM9.0000000000001842

本文引用 [1] 摘要

In the past 37 years, human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) has undergone various major transmission routes in China, with the world most complex co-circulating HIV-1 subtypes, even the prevalence is still low. In response to the first epidemic outbreak of HIV in injecting drug users and the second one by illegal commercial blood collection, China issued the Anti-Drug Law and launched the Blood Donation Act and nationwide nucleic acid testing, which has avoided 98,232 to 211,200 estimated infections and almost ended the blood product-related infection. China has been providing free antiretroviral therapy (ART) since 2003, which covered >80% of the identified patients and achieved a viral suppression rate of 91%. To bend the curve of increasing the disease burden of HIV and finally end the epidemic, China should consider constraining HIV spread through sexual transmission, narrowing the gaps in identifying HIV cases, and the long-term effectiveness and safety of ART in the future.

[7]	韩孟杰. 我国艾滋病流行形势分析和防治展望[J]. 中国艾滋病性病, 2023, 29(3):247-250. 本文引用 [4]

[8]	中国疾病预防控制中心性病艾滋病预防控制中心. 2023年12月全国艾滋病性病疫情[J]. 中国艾滋病性病, 2024, 30(3):225. 本文引用 [1]

[9]	中华人民共和国国务院. 艾滋病防治条例[EB/OL]. (2006-01-29) [2025-10-20]. https://www.gov.cn/flfg/2006-02/12/content_186324.htm. https://www.gov.cn/flfg/2006-02/12/content_186324.htm 本文引用 [1]

[10]	国务院办公厅. 国办印发《中国遏制与防治艾滋病规划(2024—2030年)》[EB/OL]. (2024-12-12) [2025-10-20]. http://cpc.people.com.cn/n1/2024/1212/c64387-40380460.html. http://cpc.people.com.cn/n1/2024/1212/c64387-40380460.html 本文引用 [2]

[11]	国务院办公厅. 国务院办公厅关于印发中国遏制与防治艾滋病行动计划(2006—2010年)的通知[EB/OL]. (2006-02-27) [2025-10-20]. https://www.gov.cn/zwgk/2006-03/10/content_224306.htm. https://www.gov.cn/zwgk/2006-03/10/content_224306.htm 本文引用 [1]

[12]	国务院办公厅. 国务院办公厅关于印发中国遏制与防治艾滋病“十二五”行动计划的通知[EB/OL]. (2012-01-13) [2025-10-20]. https://www.gov.cn/zwgk/2012-02/29/content_2079097.htm. https://www.gov.cn/zwgk/2012-02/29/content_2079097.htm 本文引用 [1]

[13]	国务院办公厅. 国务院办公厅关于印发中国遏制与防治艾滋病“十三五”行动计划的通知[EB/OL]. (2017-01-19) [2025-10-20]. https://www.gov.cn/zhengce/zhengceku/2017-02/05/content_5165514.htm. https://www.gov.cn/zhengce/zhengceku/2017-02/05/content_5165514.htm 本文引用 [1]

[14]	郝阳, 孙新华, 夏刚, 等. “四免一关怀”政策实施10年中国艾滋病防治主要进展[J]. 中国艾滋病性病, 2014, 20(4):228-232. 本文引用 [1]

[15]	吕柯, 徐鹏. 从艾滋病流行形势看我国当前所处发展阶段与防治策略[J]. 中国艾滋病性病, 2025, 31(4):429-432. 本文引用 [1]

[16]	徐鹏, 韩孟杰, 吕繁, 等. 我国艾滋病防治工作高质量发展的循证基础和践行策略[J]. 中国艾滋病性病, 2023, 29(5):491-493. 本文引用 [9]

[17]	韩孟杰, 陈清峰, 徐鹏, 等. 砥砺奋进“十三五” 艾滋病防控迈向新征程:国艾滋病防治回顾与展望[J]. 中国艾滋病性病, 2021, 27(12):1327-1331. 本文引用 [3]

[18]	Jiang Y, Qiu MF, Zhang GY, et al. Quality assurance in the HIV/AIDS laboratory network of China[J]. Int J Epidemiol, 2010, 39(Suppl 2):ii72-ii78. 本文引用 [1]

[19]	Tucker JD, Cohen MS. China’s syphilis epidemic:epidemiology,proximate determinants of spread,and control responses[J]. Curr Opin Infect Dis, 2011, 24(1):50-55. https://doi.org/10.1097/QCO.0b013e32834204bf http://journals.lww.com/00001432-201102000-00009 本文引用 [1]

[20]	Su R, Liu Y, Shan D, et al. Prevalence of HIV/syphilis co-infection among men who have sex with men in China:a systematic review and meta-analysis[J]. BMC Public Health, 2025, 25(1):1297. https://doi.org/10.1186/s12889-025-22499-5 本文引用 [1]

[21]	Zhang HX, Hsieh E, Wang L, et al. HIV/AIDS among female sex workers in China:epidemiology and recent prevention strategies[J]. Curr HIV/AIDS Rep, 2020, 17(2):151-160. https://doi.org/10.1007/s11904-019-00477-y 本文引用 [1]

[22]

Sun

, Li

, Liu

, et al. HIV/AIDS late presentation and its associated factors in China from 2010 to 2020:a systematic review and meta-analysis[J]. AIDS Res Ther, 2021, 18(1):96.

https://doi.org/10.1186/s12981-021-00415-2

本文引用 [2] 摘要

Late presentation to HIV/AIDS care presents serious health concerns, like increased transmission and high healthcare costs, increased mortality, early development of opportunistic infection, increased risk of antiretroviral therapy drug resistance. Despite the effort to contain the HIV/AIDS epidemic, LP has remained an impediment to individual immune reconstitution and public health.

[23]	郑雅静. 我国HIV/AIDS病例晚发现影响因素的研究进展[J]. 广州医科大学学报, 2020, 48(6):124-127. 本文引用 [1]

[24]	吕繁, 刘中夫, 刘玉芬, 等. 锚定目标提升能力促进艾滋病防治高质量发展[J]. 中国艾滋病性病, 2024, 30(4):335-338. 本文引用 [1]

[25]	Zhang XL, Miège P, Zhang YR. Decentralization of the provision of health services to people living with HIV/AIDS in rural China:the case of three counties[J]. Health Res Policy Syst, 2011, 9:9. 本文引用 [1]

[26]	何慧婧, 吕繁, 栾荣生, 等. 影响男男性行为人群HIV传播的社会文化因素定性研究[J]. 中华预防医学杂志, 2016, 50(10):858-862. 本文引用 [1]

[27]	吕繁. 中国艾滋病防治策略[J]. 中华预防医学杂志, 2016, 50(10): 841-845. 本文引用 [1]

[28]	汤后林, 金怡晨, 吕繁. 我国老年人群艾滋病防控现状与挑战[J]. 中华流行病学杂志, 2023, 44(11):1669-1672. 本文引用 [1]